Sun Pharma Acquisition
- All
- News
- Videos
-
Sun Pharma Acquires Canada's Aquinox Pharma For $8.2 Million, Shares Gain
Aquinox Pharmaceuticals is a research and development company focused on pharmaceutical products for the purpose of their commercialisation, Sun Pharma said.
-
Sensex Closes 224 Points Higher To Break 6-Day Fall, Nifty Reclaims 11,500
Top gainers on the 50-scrip Nifty index included Reliance Industries, Cipla, Coal India, Sun Pharma and Lupin. The Nifty Pharma rose 2.7% led by Aurobindo Pharma, which surged over 9% after the drug maker announced a $900-million acquisition in the US.
-
Sun Pharma Says US Regulator To Lift Ban On Mohali Drug Plant
Sun gained the plant along with its acquisition of Ranbaxy Laboratories in 2015 and has been attempting to fix quality control problems there that the US Food and Drug Administration (FDA) identified in 2013.
-
Sun Pharma Completes Acquisition Of 85 Per Cent Stake In JSC Biosintez
This transaction gives the company access to local manufacturing capability across multiple dosage forms in Russia,
-
Sun Pharma Completes Acquisition Of Ocular Technologies Sarl
Currently, Ocular is developing Seciera for treating dry eye disease, the city-based company said, adding the drug is currently in Phase-3 confirmatory clinical trials.
-
Indian Pharma's Focus On Acquisitions To Limit Deleveraging: Fitch
New Delhi: In line with global trends in thepharmaceuticals sector, the focus of domestic drug firms on acquisitionsto consolidate their position will limit deleveraging for thetime being, rating agency Fitch has said. "The ongoing focus of the top Indian pharma companies' onselective acquisitions to limit deleveraging over the shortterm," Fitch...
-
Continue To Remain Opportunistic For Acquisitions: Sun Pharma
Keen on inorganic expansion, Sun Pharma has said it is looking for targets that are "well managed" unlike the acquisition of Ranbaxy which continues to take significant time of the senior management.
-
Sun Pharma Sells Two US-Based Plants To Frontida BioPharm
The company however did not share financial details. The US-based firm has also agreed to offer employment to all production, quality and administrative personnel at the sites.
-
CCI Okays PVR-DT Cinemas Deal, Asks To Exclude Certain Assets
Competition Commission has approved multiplex chain PVR's proposed acquisition of DT Cinemas from DLF while directing the companies to exclude certain assets from the deal to address anti-competitive concerns.
-
Sun Pharma Completes Acquisition of InSite Vision
Drug major Sun Pharmaceutical Industries on Tuesday said it has completed acquisition of US-based eye care firm InSite Vision.
-
Sun Pharma's Tender Offer for InSite Ends, to Directly Acquire Shares
Sun Pharmaceutical Industries on Wednesday said its arm Thea Acquisition Corp plans to exercise a 'top-up' option to purchase shares directly from eyecare firm InSite Vision to hold a 90 per cent stake in the US-based company to complete a merger, after failing to get the required number of shares through a tender offer.
-
Sun Pharma Seeks Shareholders' Nod on Rs 50,000 Crore Provision
Shareholders of the company, at the 22nd AGM on September 27, 2014 had already approved the resolution to earmark Rs 50,000 crore.
-
Sun Pharma Makes Tender Offer to Acquire InSite Vision
The company "has commenced a tender offer through its indirect wholly owned subsidiary, Thea Acquisition Corporation, for all of the outstanding shares of common stock of InSite Vision Incorporated for $0.35 per share in cash, without interest and less any required withholding taxes," Sun Pharma said in a statement.
-
Sun Pharma's Open Offer for Zenotech Stake Gets Tepid Response
Sun Pharma decided to make the open offer after its acquisition of Ranbaxy, which had held significant stake in Zenotech.
-
Open to Acquisitions but Selective With Targets: Sun Pharma
Fresh from its $4-billion takeover of Ranbaxy, Sun Pharmaceutical Industries says it is open to further acquisitions but will consider only targets "which will not require significant amount of management involvement".
-
Sun Pharma Acquires Canada's Aquinox Pharma For $8.2 Million, Shares Gain
Aquinox Pharmaceuticals is a research and development company focused on pharmaceutical products for the purpose of their commercialisation, Sun Pharma said.
-
Sensex Closes 224 Points Higher To Break 6-Day Fall, Nifty Reclaims 11,500
Top gainers on the 50-scrip Nifty index included Reliance Industries, Cipla, Coal India, Sun Pharma and Lupin. The Nifty Pharma rose 2.7% led by Aurobindo Pharma, which surged over 9% after the drug maker announced a $900-million acquisition in the US.
-
Sun Pharma Says US Regulator To Lift Ban On Mohali Drug Plant
Sun gained the plant along with its acquisition of Ranbaxy Laboratories in 2015 and has been attempting to fix quality control problems there that the US Food and Drug Administration (FDA) identified in 2013.
-
Sun Pharma Completes Acquisition Of 85 Per Cent Stake In JSC Biosintez
This transaction gives the company access to local manufacturing capability across multiple dosage forms in Russia,
-
Sun Pharma Completes Acquisition Of Ocular Technologies Sarl
Currently, Ocular is developing Seciera for treating dry eye disease, the city-based company said, adding the drug is currently in Phase-3 confirmatory clinical trials.
-
Indian Pharma's Focus On Acquisitions To Limit Deleveraging: Fitch
New Delhi: In line with global trends in thepharmaceuticals sector, the focus of domestic drug firms on acquisitionsto consolidate their position will limit deleveraging for thetime being, rating agency Fitch has said. "The ongoing focus of the top Indian pharma companies' onselective acquisitions to limit deleveraging over the shortterm," Fitch...
-
Continue To Remain Opportunistic For Acquisitions: Sun Pharma
Keen on inorganic expansion, Sun Pharma has said it is looking for targets that are "well managed" unlike the acquisition of Ranbaxy which continues to take significant time of the senior management.
-
Sun Pharma Sells Two US-Based Plants To Frontida BioPharm
The company however did not share financial details. The US-based firm has also agreed to offer employment to all production, quality and administrative personnel at the sites.
-
CCI Okays PVR-DT Cinemas Deal, Asks To Exclude Certain Assets
Competition Commission has approved multiplex chain PVR's proposed acquisition of DT Cinemas from DLF while directing the companies to exclude certain assets from the deal to address anti-competitive concerns.
-
Sun Pharma Completes Acquisition of InSite Vision
Drug major Sun Pharmaceutical Industries on Tuesday said it has completed acquisition of US-based eye care firm InSite Vision.
-
Sun Pharma's Tender Offer for InSite Ends, to Directly Acquire Shares
Sun Pharmaceutical Industries on Wednesday said its arm Thea Acquisition Corp plans to exercise a 'top-up' option to purchase shares directly from eyecare firm InSite Vision to hold a 90 per cent stake in the US-based company to complete a merger, after failing to get the required number of shares through a tender offer.
-
Sun Pharma Seeks Shareholders' Nod on Rs 50,000 Crore Provision
Shareholders of the company, at the 22nd AGM on September 27, 2014 had already approved the resolution to earmark Rs 50,000 crore.
-
Sun Pharma Makes Tender Offer to Acquire InSite Vision
The company "has commenced a tender offer through its indirect wholly owned subsidiary, Thea Acquisition Corporation, for all of the outstanding shares of common stock of InSite Vision Incorporated for $0.35 per share in cash, without interest and less any required withholding taxes," Sun Pharma said in a statement.
-
Sun Pharma's Open Offer for Zenotech Stake Gets Tepid Response
Sun Pharma decided to make the open offer after its acquisition of Ranbaxy, which had held significant stake in Zenotech.
-
Open to Acquisitions but Selective With Targets: Sun Pharma
Fresh from its $4-billion takeover of Ranbaxy, Sun Pharmaceutical Industries says it is open to further acquisitions but will consider only targets "which will not require significant amount of management involvement".
